Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Protein Regulator of Tumor Suppressor ARF & NF-κB

NCT00896948 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT00896948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00896948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Protein Regulator of Tumor Suppressor ARF & NF-κB
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 31, 2005
Completion date
Not reported
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer